 |
 |
|
|
|
|
|
|
|
| | | |
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
1
.
SEC COMMISSION OPINION
|
EXTRACTED KEY WORDS
FINANCIAL STATEMENTS SECURITIES COMMISSION REVIEW ASSETS EXCHANGE ACT CONTINUED LISTING REPORTS JUDGEMENT DELINQUENT FILINGS NASDAQ ADVERTISING CREDITS FEDERAL SECURITIES LAWS TRANSACTION NASD MARKETPLACE RULE NASDAQ STAFF NATIONAL ASSOCIATION SECURITIES DEALERS FRAUDULENT OVERSTATEMENT REVIEW PROCEEDING CONTINUED INCLUSION NASDAQ SMALLCAP MARKET REVIEW COUNCIL PUBLIC FILINGS REGISTERED SECURITIES ASSOCIATION ACCOUNTING TREATMENT SERIOUSLY DELINQUENT PERIODIC REPORTS |
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
SECURITIES EXCHANGE ACT OF 1934
Rel. No. 42060 / October 26, 1999
Admin. Proc. File No. 3-9667
In the Matter of the Application of
HEALTHTECH INTERNATIONAL, INC.
c/o Gregory A. Larson, Esq.
Mesa, Arizona 85204
For Review of Action Taken by the
NATIONAL ASSOCIATION OF SECURITIES DEALERS, INC.
OPINION OF THE COMMISSION REGISTERED SECURITIES ASSOCIATION -- REVIEW
OF DELISTING Denial of Continued Listing
Registered securities association acted consistently with its rules
and the purposes of the federal securities laws in denying an issuer's
request to continue listing its securities on the association's
automatic quotation system because (1) the value assigned to certain
assets raised questions as to the propriety of the accounting
treatment used in the Company's financial statements; (2) the issuer
had consented to entry of final judgment in a complaint alleging,
among other things, fraudulent overstatement of its assets; and (3)
the issuer was seriously delinquent in filing its periodic reports.
Held, review proceeding is dismissed.
APPEARANCES
Gregory A. Larson, for HealthTech International, Inc.
Robert E. Aber, Arnold P. Golub, and David A. Spotts, for the Nasdaq
Stock Market, Inc.
Appeal Filed August 5, 1998
Briefing Completed November 18, 1998
I.
HealthTech International, Inc. ("HealthTech" or the "Company") has
SNIPPETS:
|
|
|
| | | |
|
|
